The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Universal Real-Time PCR for the Detection and Quantification of Adeno-Associated Virus Serotype 2-Derived Inverted Terminal Repeat Sequences
Abstract
Viral vectors based on various naturally occurring adeno-associated virus (AAV) serotypes are among the most promising tools in human gene therapy. For the production of recombinant AAV (rAAV) vectors, researchers are focusing predominantly on cross-packaging an artificial AAV genome based on serotype 2 (AAV2) into capsids derived from other serotypes. Within the packaged genome the inverted terminal repeats (ITRs) are the only cis-acting viral elements required for rAAV vector generation and depict the lowest common denominator of all AAV2-derived vector genomes. Up to now, no quantitative PCR (qPCR) for the detection and quantification of AAV2 ITRs could be established because of their extensive secondary hairpin structure formation. Current qPCR-based methods are therefore targeting vector-encoded transgenes or regulatory elements. Herein we establish a molecular biological method that allows accurate and reproducible quantification of AAV2 genomes on the basis of an AAV2 ITR sequence-specific qPCR. Primers and labeled probe are located within the ITR sequence and have been designed to detect both wild-type AAV2 and AAV2-based vectors. This method is suitable for detecting single-stranded DNA derived from AAV2 vector particles and double-stranded DNA derived from vector plasmids. The limit of detection has been determined as 50 ITR sequence copies per reaction, by comparison with a plasmid standard. In conclusion, this method describes the first qPCR system facilitating the detection and quantification of AAV2 ITR sequences. Because this method can be used universally for all AAV2 genome-based vectors, it will significantly simplify rAAV2 vector titrations in the future. Aurnhammer and colleagues have developed a quantitative PCR method for accurate, sensitive, and reproducible quantification of adeno-associated virus type 2 (AAV2) genomes based on amplifying sequences within the inverted terminal repeat sequences. This method can detect both wild-type and recombinant AAV2 vectors, and is suitable for single- and double-stranded DNA derived from either vector particles or plasmids.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments
Bustin, S. A., Benes, V., Garson, J. A., Hellemans, J., Huggett, J., Kubista, M., Mueller, R., Nolan, T., Pfaffl, M. W., Shipley, G. L., et al. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2008.112797 · Cited by 16,303
Adenovirus-Associated Defective Virus Particles
Atchison, R. W., Casto, B. C., & Hammon, W. M. (1965) · Science · doi:10.1126/science.149.3685.754 · Cited by 1,004
Gene therapy using adeno-associated virus vectors
Daya, S., & Berns, K. I. (2008) · Clinical Microbiology Reviews · doi:10.1128/cmr.00008-08 · Cited by 926
Nucleotide sequence and organization of the adeno-associated virus 2 genome
Srivastava, A., Lusby, E. W., & Berns, K. I. (1983) · Journal of Virology · doi:10.1128/jvi.45.2.555-564.1983 · Cited by 721
Production and characterization of adeno-associated viral vectors
Grieger, J. C., Choi, V. W., & Samulski, R. J. (2006) · Nature Protocols · doi:10.1038/nprot.2006.207 · Cited by 581
McCarty, D. M., Fu, H., Monahan, P. E., Toulson, C. E., Naik, P., & Samulski, R. J. (2003) · Gene Therapy · doi:10.1038/sj.gt.3302134 · Cited by 547
Samulski, R. J., Chang, L. S., & Shenk, T. (1987) · Journal of Virology · doi:10.1128/jvi.61.10.3096-3101.1987 · Cited by 449
A viral assembly factor promotes AAV2 capsid formation in the nucleolus
Sonntag, F., Schmidt, K., & Kleinschmidt, J. A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1001673107 · Cited by 392
Wang, Z., Ma, H.-I., Li, J., Sun, L., Zhang, J., & Xiao, X. (2003) · Gene Therapy · doi:10.1038/sj.gt.3302133 · Cited by 367
Thomas, C. E., Storm, T. A., Huang, Z., & Kay, M. A. (2004) · Journal of Virology · doi:10.1128/jvi.78.6.3110-3122.2004 · Cited by 358
Store-operated CRAC channels: function in health and disease
Parekh, A. B. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3136 · Cited by 317
Bish, L. T., Morine, K., Sleeper, M. M., Sanmiguel, J., Wu, D., Gao, G., Wilson, J. M., & Sweeney, H. L. (2008) · Human Gene Therapy · doi:10.1089/hum.2008.123 · Cited by 292
Wobus, C. E., Hügle-Dörr, B., Girod, A., Petersen, G., Hallek, M., & Kleinschmidt, J. A. (2000) · Journal of Virology · doi:10.1128/jvi.74.19.9281-9293.2000 · Cited by 273 · cited 1×
“A second rationale is based on the detection of specific capsid proteins by enzyme-linked immunosorbent assays (ELISAs) (Grimm et al. , 1999; Wobus et al. , 2000).”
Cloning of infectious adeno-associated virus genomes in bacterial plasmids
Laughlin, C. A., Tratschin, J.-D., Coon, H., & Carter, B. J. (1983) · Gene · doi:10.1016/0378-1119(83)90217-2 · Cited by 266
Adeno-associated virus: from defective virus to effective vector
Gonçalves, M. A. (2005) · Virology Journal · doi:10.1186/1743-422x-2-43 · Cited by 264
Nucleotide sequence of the inverted terminal repetition in adeno-associated virus DNA
Lusby, E., Fife, K. H., & Berns, K. I. (1980) · Journal of Virology · doi:10.1128/jvi.34.2.402-409.1980 · Cited by 234
Adeno-associated virus vectors for gene therapy: more pros than cons?
Monahan, P. E., & Samulski, R. J. (2000) · Molecular Medicine Today · doi:10.1016/s1357-4310(00)01810-4 · Cited by 227
Adeno-Associated Virus Vectors in Clinical Trials
Carter, B. J. (2005) · Human Gene Therapy · doi:10.1089/hum.2005.16.541 · Cited by 206
Grimm, D., Kern, A., Pawlita, M., Ferrari, F. K., Samulski, R. J., & Kleinschmidt, J. A. (1999) · Gene Therapy · doi:10.1038/sj.gt.3300946 · Cited by 195 · cited 2×
“Typically, rAAV vector genomes consist of approximately 4.5 kilobases of ssDNA (Grimm et al. , 1999, 2005; Carter, 2005).”
InfluentialYang, C. C., Xiao, X., Zhu, X., Ansardi, D. C., Epstein, N. D., Frey, M. R., Matera, A. G., & Samulski, R. J. (1997) · Journal of Virology · doi:10.1128/jvi.71.12.9231-9247.1997 · Cited by 178
Biology of AAV Serotype Vectors in Liver-Directed Gene Transfer to Nonhuman Primates
Gao, G., Lu, Y., Calcedo, R., Grant, R. L., Bell, P., Wang, L., Figueredo, J., Lock, M., & Wilson, J. M. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2005.08.017 · Cited by 170
Rohr, U., Wulf, M.-A., Stahn, S., Steidl, U. G., Haas, R. R., & Kronenwett, R. (2002) · Journal of Virological Methods · doi:10.1016/s0166-0934(02)00138-6 · Cited by 146
The adeno-associated virus rep gene suppresses herpes simplex virus-induced DNA amplification
Heilbronn, R., Bürkle, A., Stephan, S., & Hausen, H. Z. (1990) · Journal of Virology · doi:10.1128/jvi.64.6.3012-3018.1990 · Cited by 132
Yan, Z., Zak, R., Zhang, Y., & Engelhardt, J. F. (2005) · Journal of Virology · doi:10.1128/jvi.79.1.364-379.2005 · Cited by 107
Plus and Minus Single-Stranded DNA Separately Encapsidated in Adeno-Associated Satellite Virions
Mayor, H. D., Torikai, K., Melnick, J. L., & Mandel, M. (1969) · Science · doi:10.1126/science.166.3910.1280 · Cited by 100
AAVs Anatomy: Roadmap for Optimizing Vectors for Translational Success
Mitchell, A. M., Nicolson, S. C., Warischalk, J. K., & Samulski, R. J. (2010) · Current Gene Therapy · doi:10.2174/156652310793180706 · Cited by 97
Adeno-Associated Virus Vectors for Short Hairpin RNA Expression
Grimm, D., Pandey, K., & Kay, M. A. (2005) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(04)92023-x · Cited by 82
The next step in gene delivery: Molecular engineering of adeno-associated virus serotypes
Wang, J., Faust, S. M., & Rabinowitz, J. E. (2010) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2010.10.017 · Cited by 69
Effects of Adeno-Associated Virus DNA Hairpin Structure on Recombination
Choi, V. W., Samulski, R. J., & McCarty, D. M. (2005) · Journal of Virology · doi:10.1128/jvi.79.11.6801-6807.2005 · Cited by 62
Safety of adeno-associated virus gene therapy vectors: a current evaluation
Monahan, P. E., Jooss, K. U., & Sands, M. S. (2002) · Expert Opinion on Drug Safety · doi:10.1517/14740338.1.1.79 · Cited by 61
Reengineered AAV Vectors: Old Dog, New Tricks
The University of North Carolina at Chapel Hill University Libraries (2020) · PubMed · doi:10.17615/9jm8-4r29 · Cited by 20
McAlister, V. J., & Owens, R. A. (2007) · Journal of Virology · doi:10.1128/jvi.00746-07 · Cited by 14
Research works printed but not linked: 2
- 10.1093/nar/11.4.999 · doi:10.1093/nar/11.4.999
- Knipe D.M., 2001, Fundamental Virology
Cited by
CRISPR/Cas9 β-globin gene targeting in human haematopoietic stem cells
Dever, D. P., Bak, R. O., Reinisch, A., Camarena, J., Washington, G., Nicolas, C. E., Pavel-Dinu, M., Saxena, N., Wilkens, A. B., Mantri, S., et al. (2016) · Nature · doi:10.1038/nature20134 · Cited by 864
Vakulskas, C. A., Dever, D. P., Rettig, G. R., Turk, R., Jacobi, A. M., Collingwood, M. A., Bode, N. M., McNeill, M. S., Yan, S., Camarena, J., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0137-0 · Cited by 782
Cell Types of the Human Retina and Its Organoids at Single-Cell Resolution
Cowan, C. S., Renner, M., De Gennaro, M., Gross-Scherf, B., Goldblum, D., Hou, Y., Munz, M., Rodrigues, T. M., Krol, J., Szikra, T., et al. (2020) · Cell · doi:10.1016/j.cell.2020.08.013 · Cited by 654
A Multifunctional AAV-CRISPR-Cas9 and Its Host Response
Chew, W. L., Tabebordbar, M., Cheng, J. K. W., Mali, P., Wu, E. Y., Ng, A. H. M., Zhu, K., Wagers, A. J., & Church, G. M. (2016) · Nature Methods · doi:10.1038/nmeth.3993 · Cited by 617
Yesbolatova, A., Saito, Y., Kitamoto, N., Makino-Itou, H., Ajima, R., Nakano, R., Nakaoka, H., Fukui, K., Gamo, K., Tominari, Y., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19532-z · Cited by 533
Metadata
- Authors
- Aurnhammer, C., Haase, M., Muether, N., Hausl, M., Rauschhuber, C., Huber, I., Nitschko, H., Busch, U., Sing, A., Ehrhardt, A., & Baiker, A.
- Venue
- Human Gene Therapy Methods
- Publisher
- SAGE Publications
- Published
- 2012-02
- Volume
- 23
- Issue
- 1
- Pages
- 18-28
- ISSN
- 1946-6536 (ISSN-L)
- 1946-6544
- OpenAlex
- W1990559406
- Cited by
- 490
- References
- 32
- FWCI
- 6.91
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.liebertpub.com/nv/resources-tools/text-and-data-mining-policy/121/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.